These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 7372548

  • 1. In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic.
    Mine Y, Kamimura T, Nonoyama S, Nishida M, Goto S, Kuwahara S.
    J Antibiot (Tokyo); 1980 Jan; 33(1):36-43. PubMed ID: 7372548
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent.
    Neu HC, Kamimura T.
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1013-23. PubMed ID: 7271270
    [Abstract] [Full Text] [Related]

  • 3. In vitro synergism of FR-31564, a new phosphonic acid antibiotic.
    Yokota Y, Murakawa T, Nishida M.
    J Antibiot (Tokyo); 1981 Jul; 34(7):876-83. PubMed ID: 7287590
    [Abstract] [Full Text] [Related]

  • 4. [Antibacterial activities of fosfomycin against several fresh clinical isolates--comparison of the test methods for antibacterial activity].
    Hara T, Araake M, Watabe H.
    Jpn J Antibiot; 2002 Dec; 55(6):844-54. PubMed ID: 12621737
    [Abstract] [Full Text] [Related]

  • 5. [Antibacterial activities of monobactams against fresh clinical isolates].
    Deguchi K, Yokota N, Koguchi M, Nakane Y, Fukayama S, Nishimura Y, Oda S, Tanaka S, Kato M, Sato K.
    Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
    [Abstract] [Full Text] [Related]

  • 6. In vitro investigations with fosfomycin on Mueller-Hinton agar with and without glucose-6-phosphate.
    Grimm H.
    Infection; 1979 Nov; 7(5):256-9. PubMed ID: 389806
    [Abstract] [Full Text] [Related]

  • 7. FR-31564, a new phosphonic acid antibiotic: bacterial resistance and membrane permeability.
    Kojo H, Shigi Y, Nishida M.
    J Antibiot (Tokyo); 1980 Jan; 33(1):44-8. PubMed ID: 7378171
    [Abstract] [Full Text] [Related]

  • 8. [Bacteriological studies on fosfomycin. Antibacterial activity in vitro and in vivo (author's transl)].
    Miyauchi K, Yoshida T, Kasai T, Saito T, Hirano H.
    Jpn J Antibiot; 1975 Jun; 28(3):320-30. PubMed ID: 807758
    [Abstract] [Full Text] [Related]

  • 9. Fosfomycin, antimicrobial activity in vitro and in vivo.
    Goto S.
    Chemotherapy; 1977 Jun; 23 Suppl 1():63-74. PubMed ID: 401721
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey.
    Demir T, Buyukguclu T.
    Int J Infect Dis; 2013 Nov; 17(11):e966-70. PubMed ID: 23742831
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial activity of dactimicin in vitro compared with that of dibekacin, netilmicin, sisomicin and micronomicin.
    Inouye S, Hara T, Matsuhashi Y, Kitasato I.
    Drugs Exp Clin Res; 1989 Nov; 15(10):455-63. PubMed ID: 2632214
    [Abstract] [Full Text] [Related]

  • 12. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T, Tateda E, Hiramatsu K, Yokota T.
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [Abstract] [Full Text] [Related]

  • 13. Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric study.
    Bielen L, Likić R, Erdeljić V, Mareković I, Firis N, Grgić-Medić M, Godan A, Tomić I, Hunjak B, Markotić A, Bejuk D, Tičić V, Balzar S, Bedenić B.
    Croat Med J; 2018 Apr 30; 59(2):56-64. PubMed ID: 29740989
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T, Otsuki M, Hatano K, Nishihara Y.
    Chemotherapy; 1994 Apr 30; 40(3):167-82. PubMed ID: 8205935
    [Abstract] [Full Text] [Related]

  • 15. New perspectives for reassessing fosfomycin: applicability in current clinical practice.
    Candel FJ, Matesanz David M, Barberán J.
    Rev Esp Quimioter; 2019 May 30; 32 Suppl 1(Suppl 1):1-7. PubMed ID: 31131586
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo antibacterial activities of K-4619, a new semisynthetic aminoglycoside.
    Saino Y, Hattori Y, Koshi T, Kobayashi F, Oda T, Mitsuhashi S.
    Antimicrob Agents Chemother; 1984 Aug 30; 26(2):187-91. PubMed ID: 6548350
    [Abstract] [Full Text] [Related]

  • 17. [Antibacterial kinetics of fosfomycin (author's transl)].
    Gevaudan MJ, Mallet MN, Charrel J, Dalmas N, Gulian C, Gevaudan P.
    Ann Biol Clin (Paris); 1979 Aug 30; 37(6):327-30. PubMed ID: 547759
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial activity of fosfomycin in vitro.
    Forsgren A, Walder M.
    J Antimicrob Chemother; 1983 May 30; 11(5):467-71. PubMed ID: 6874631
    [Abstract] [Full Text] [Related]

  • 19. Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal fosA Gene.
    Ito R, Mustapha MM, Tomich AD, Callaghan JD, McElheny CL, Mettus RT, Shanks RMQ, Sluis-Cremer N, Doi Y.
    mBio; 2017 Aug 29; 8(4):. PubMed ID: 28851843
    [Abstract] [Full Text] [Related]

  • 20. [Fosfomycin, a new antibiotic: in vitro activity compared with mezlocillin, cefuroxime and gentamicin].
    Lindenschmidt EG, Schassan HH.
    Immun Infekt; 1980 Aug 29; 8(4):121-6. PubMed ID: 6453080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.